Brickell Biotech, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was USD 0.404 million compared to USD 1.82 million a year ago. Net loss was USD 39.47 million compared to USD 20.91 million a year ago.

Basic loss per share from continuing operations was USD 22.05 compared to USD 38.25 a year ago.